InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 12.52
+0.02 (0.16%)
Oct 21, 2026, 2:43 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 26.47 billion as of October 20, 2026. It is the 4,750th most valuable company in the world and the 232nd biggest in Hong Kong. Its market cap has decreased by 4.61% in one year.
Market Cap
26.47B
Enterprise Value
19.95B
Revenue
3.21B
Global Rank
Country Rank
#232 Hong Kong
PE Ratio
21.42
ChartMarket Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 26.47B, an increase of 115.59%. That is a compound annual growth rate of 12.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 26.47B | 11.75% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 56.84B |
| Biocytogen Pharmaceuticals (Beijing) | 38.57B |
| 3SBio | 36.11B |
| Shanghai Junshi Biosciences | 33.14B |
| Shanghai Henlius Biotech | 29.53B |
| Keymed Biosciences | 25.50B |
| Zai Lab | 23.08B |
| InSilico Medicine Cayman TopCo | 22.18B |